Lozada, Reynaldo T.

HRN: 11-63-02  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/03/2025
12/10/2025
IV
500mg
Q12h
Sepsis Sec To Sacral Decubitus Ulcer
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines